These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35489745)

  • 21. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
    Ribeiro EA; Maleki Z
    J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16 status and high-risk human papilloma virus infection in squamous cell carcinoma of the nasal vestibule.
    Yamamura K; Saito Y; Kobayashi K; Mukai T; Fukuoka O; Akashi K; Yoshida M; Ando M; Yamasoba T
    Auris Nasus Larynx; 2023 Dec; 50(6):942-947. PubMed ID: 37098459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
    Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
    Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 and p16
    Mohanty SK; Mishra SK; Bhardwaj N; Sardana R; Jaiswal S; Pattnaik N; Pradhan D; Sharma S; Kaushal S; Baisakh MR; Das S; Pradhan MR; Satapathy K; Pattnaik A; Sharma SK; Khadenga CR; Das S; Rath D; Nanda B; Parwani AV
    Clin Genitourin Cancer; 2021 Dec; 19(6):510-520. PubMed ID: 34348854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E-cadherin, COX-2, MYC, and MLH1.
    de Lima MAP; Cavalcante RB; da Silva CGL; Nogueira RLM; Macedo GEC; de Galiza LE; Pinheiro JV; Maia Filho PHB; Santos SF; Rabenhorst SHB
    Oral Dis; 2022 May; 28(4):1104-1122. PubMed ID: 33660890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between p16 expression and prognosis in different anatomic subsites of OSCC.
    Ni Y; Zhang X; Wan Y; Dun Tang K; Xiao Y; Jing Y; Song Y; Huang X; Punyadeera C; Hu Q
    Cancer Biomark; 2019; 26(3):375-383. PubMed ID: 31594213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
    Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
    Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of p16-overexpression on overall and progression-free survival outcomes in oral cavity squamous cell carcinomas: A semi-national, population-based study.
    Schneider K; Jakobsen KK; Jensen JS; Wessel I; Christensen A; Specht L; Lelkaitis G; Mirian C; Buchwald CV; Grønhøj C
    Oral Oncol; 2020 Dec; 111():105031. PubMed ID: 33069060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
    Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
    Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis.
    Svajdler M; Nemcova J; Dubinsky P; Metelkova A; Svajdler P; Straka Ľ; Sakar R; Daum O; Michal M; Skalova A; Mezencev R
    Neoplasma; 2020 Nov; 67(6):1456-1463. PubMed ID: 32853018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
    Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
    Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
    Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany.
    Reuschenbach M; Kansy K; Garbe K; Vinokurova S; Flechtenmacher C; Toth C; Prigge ES; Thiele OC; Reinert S; Hoffmann J; von Knebel Doeberitz M; Freier K
    Oral Oncol; 2013 Sep; 49(9):937-942. PubMed ID: 23608471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of an antibody-based detection system for human papilloma virus infection in oral squamous cell carcinoma.
    Blatt S; Pabst A; Zimmer S; Walter C; Al-Nawas B; Krüger M
    Clin Oral Investig; 2021 May; 25(5):2837-2843. PubMed ID: 33098030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.